Study tests synthetic MRI software on multiple sclerosis patients
Dr. Tobias Granberg, postdoctoral research fellow at Massachusetts General Hospital’s Martinos Center for Biomedical Imaging, will talk about the use of SyMRI for Multiple Sclerosis (MS) patients at RSNA in Chicago in December.
In an RSNA preview article published on AuntMinnie, Tobias comments that “Synthetic MRI may reduce the scan time in multiple sclerosis patients while additionally delivering the ability to obtain any desired weighted contrast post-hoc, thus possibly increasing the sensitivity for pathological changes in the brain.”
He also adds that SyMRI “can provide robust volumetric brain measurements that can be obtained in tens of seconds without the need for manual intervention within PACS, thereby lowering the threshold for implementing these quantitative biomarkers into clinical practice.”
The title of the presentation is ”Clinical Feasibility of Synthetic MRI in Multiple Sclerosis: a Diagnostic and Volumetric Validation Study”.
Time and place: Tuesday, 1 December, 2015 at 10:50 AM. RSNA 101st Scientific Assembly and Annual Meeting, McCormick Place, Chicago, Illinois.
The study was carried out at the Karolinska University Hospital in Sweden.